Molecules 2013, 18(10), 12857-12876; doi:10.3390/molecules181012857
Article

Chemometric Evaluation of Urinary Steroid Hormone Levels as Potential Biomarkers of Neuroendocrine Tumors

1,* email, 1email, 1email, 1email, 2email, 2email, 3email, 4email and 4email
Received: 7 August 2013; in revised form: 25 September 2013 / Accepted: 10 October 2013 / Published: 16 October 2013
(This article belongs to the Special Issue Steroids)
This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Abstract: Neuroendocrine tumors (NETs) are uncommon tumors which can secrete specific hormone products such as peptides, biogenic amines and hormones. So far, the diagnosis of NETs has been difficult because most NET markers are not specific for a given tumor and none of the NET markers can be used to fulfil the criteria of high specificity and high sensitivity for the screening procedure. However, by combining the measurements of different NET markers, they become highly sensitive and specific diagnostic tests. The aim of the work was to identify whether urinary steroid hormones can be identified as potential new biomarkers of NETs, which could be used as prognostic and clinical course monitoring factors. Thus, a rapid and sensitive reversed-phase high-performance liquid chromatographic method (RP-HPLC) with UV detection has been developed for the determination of cortisol, cortisone, corticosterone, testosterone, epitestosterone and progesterone in human urine. The method has been validated for accuracy, precision, selectivity, linearity, recovery and stability. The limits of detection and quantification were 0.5 and 1 ng mL−1 for each steroid hormone, respectively. Linearity was confirmed within a range of 1–300 ng mL−1 with a correlation coefficient greater than 0.9995 for all analytes. The described method was successfully applied for the quantification of six endogenous steroid levels in human urine. Studies were performed on 20 healthy volunteers and 19 patients with NETs. Next, for better understanding of tumor biology in NETs and for checking whether steroid hormones can be used as potential biomarkers of NETs, a chemometric analysis of urinary steroid hormone levels in both data sets was performed.
Keywords: neuroendocrine tumors (NETs); biomarkers; steroid hormones; HPLC determination; chemometric analysis
PDF Full-text Download PDF Full-Text [674 KB, uploaded 18 June 2014 20:13 CEST]

Export to BibTeX |
EndNote


MDPI and ACS Style

Plenis, A.; Miękus, N.; Olędzka, I.; Bączek, T.; Lewczuk, A.; Woźniak, Z.; Koszałka, P.; Seroczyńska, B.; Skokowski, J. Chemometric Evaluation of Urinary Steroid Hormone Levels as Potential Biomarkers of Neuroendocrine Tumors. Molecules 2013, 18, 12857-12876.

AMA Style

Plenis A, Miękus N, Olędzka I, Bączek T, Lewczuk A, Woźniak Z, Koszałka P, Seroczyńska B, Skokowski J. Chemometric Evaluation of Urinary Steroid Hormone Levels as Potential Biomarkers of Neuroendocrine Tumors. Molecules. 2013; 18(10):12857-12876.

Chicago/Turabian Style

Plenis, Alina; Miękus, Natalia; Olędzka, Ilona; Bączek, Tomasz; Lewczuk, Anna; Woźniak, Zofia; Koszałka, Patrycja; Seroczyńska, Barbara; Skokowski, Jarosław. 2013. "Chemometric Evaluation of Urinary Steroid Hormone Levels as Potential Biomarkers of Neuroendocrine Tumors." Molecules 18, no. 10: 12857-12876.

Molecules EISSN 1420-3049 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert